Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model

Breast Cancer Research and Treatment

Volumn 117, Issue 3, 2009, Pages 517-524

  Ruhlen, Rachel L ^a   Willbrand, Dana M ^a   Besch Williford, Cynthia L ^b   Ma, Lixin ^a,c   Shull, James D ^d   Sauter, Edward R ^a  

^a University of Missouri   (United States)

^b Department of Veterinary Biomedical Sciences ^*  (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

ACI rat; Breast cancer etiology; Breast cancer prevention; Estrogen receptor; Rat model; Tamoxifen

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUGUST COPENHAGEN IRISH RAT; BREAST CANCER; CONTROLLED STUDY; FEMALE; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENIC RAT; TREATMENT DURATION; TUMOR VOLUME;

ANIMALS; ANIMALS, CONGENIC; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; RATS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 70349578806     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0169-0     Document Type: Article

References (36)

1. JD Yager NE Davidson 2006 Estrogen carcinogenesis in breast cancer N Engl J Med 354 3 270 282 16421368 10.1056/NEJMra050776 1:CAS:528: DC%2BD28Xls1KjtQ%3D%3D (Pubitemid 43113032)
2. Anonymous: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on hormonal factors in breast cancer.[see comment][erratum appears in Lancet 1997 Nov 15;350(9089):1484]. Lancet 1997, 350(9084):1047-1059
3. JE Rossouw GL Anderson RL Prentice, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 3 321 333 12117397 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D
4. B Fisher JP Costantino DL Wickerham, et al. 1998 Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project p-1 study. [see comment] J Natl Cancer Inst 90 18 1371 1388 9747868 10.1093/jnci/90.18.1371 1:CAS:528:DyaK1cXmtlelurs%3D
5. JD Shull TJ Spady MC Snyder, et al. 1997 Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma Carcinogenesis 18 8 1595 1601 9276635 10.1093/carcin/18.8.1595 1:CAS:528:DyaK2sXlsF2rtL8%3D (Pubitemid 28134784)
6. TJ Spady DM Harvell MC Snyder, et al. 1998 Estrogen-induced tumorigenesis in the Copenhagen rat disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas Cancer Lett 124 1 95 103 9500197 10.1016/S0304-3835(97)00455-2 1:CAS:528:DyaK1cXnt12msQ%3D%3D (Pubitemid 28073814)
7. JD Shull KL Pennington TM Reindl, et al. 2001 Susceptibility to estrogen-induced mammary cancer segregates as an incompletely dominant phenotype in reciprocal crosses between the ACI and Copenhagen rat strains Endocrinology 142 12 5124 5130 11713205 10.1210/en.142.12.5124 1:CAS:528:DC%2BD3MXovVSnur4%3D (Pubitemid 33131938)
8. KA Gould M Tochacek BS Schaffer, et al. 2004 Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18 Genetics 168 4 2113 2125 15611180 10.1534/genetics.104.033878 1:CAS:528:DC%2BD2MXhtVyjsLY%3D (Pubitemid 40066348)
9. BS Schaffer CM Lachel KL Pennington, et al. 2006 Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway × ACI intercross Cancer Res 66 15 7793 7800 16885383 10.1158/0008-5472.CAN-06-0143 1:CAS:528: DC%2BD28XnsFyqs78%3D (Pubitemid 44289240)
10. JD Shull 2007 The rat oncogenome: comparative genetics and genomics of rat models of mammary carcinogenesis Breast Dis 28 69 86 18057545 1:CAS:528:DC%2BD2sXhtlClsrrE
11. JJ Li D Papa MF Davis, et al. 2002 Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer Mol Carcinog 33 1 56 65 11807958 10.1002/mc.10022 (Pubitemid 34052307)
12. EW Blank P-Y Wong R Lakshamanaswamy, et al. 2008 Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats Proc Natl Acad Sci USA 105 9 3527 3532 18299580 10.1073/pnas.0710535105 1:CAS:528:DC%2BD1cXjtlams70%3D (Pubitemid 351723586)
13. DF Easton KA Pooley AM Dunning, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 7148 1087 1093 17529967 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D (Pubitemid 47014426)
14. DM Harvell TE Strecker M Tochacek, et al. 2000 Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers Proc Natl Acad Sci USA 97 6 2779 2784 10688907 10.1073/pnas.050569097 1:CAS:528:DC%2BD3cXitVahsLs%3D (Pubitemid 30159248)
15. JJ Li SJ Weroha WL Lingle, et al. 2004 Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats Proc Natl Acad Sci USA 101 52 18123 18128 15601761 10.1073/pnas.0408273101 1:CAS:528:DC%2BD2MXjsl2muw%3D%3D (Pubitemid 40054084)
16. T Adamovic L Roshani L Chen, et al. 2007 Nonrandom pattern of chromosome aberrations in 17beta-estradiol-induced rat mammary tumors: indications of distinct pathways for tumor development Genes Chromosomes Cancer 46 5 459 469 17285573 10.1002/gcc.20428 1:CAS:528:DC%2BD2sXjsVShsL4%3D (Pubitemid 46449248)
17. DM Harvell TE Strecker B Xie, et al. 2002 Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat Carcinogenesis 23 1 161 169 11756237 10.1093/carcin/23.1.161 1:CAS:528:DC%2BD38XptFSqsw%3D%3D
18. HS Aiyer C Srinivasan RC Gupta 2008 Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats Nutr Cancer 60 2 227 18444155 10.1080/01635580701624712
19. TJ Spady DM Harvell A Lemus-Wilson, et al. 1999 Modulation of estrogen action in the rat pituitary and mammary glands by dietary energy consumption J Nutr 129 2S Suppl 587S 590S 10064338 1:CAS:528:DyaK1MXhvFGqtLo%3D
20. TE Strecker TJ Spady BS Schaffer, et al. 2005 Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains Genetics 169 4 2189 2197 15687265 10.1534/genetics.104.039370 1:CAS:528:DC%2BD2MXltlSjs70%3D (Pubitemid 40695629)
21. SG Kurz KK Hansen MT McLaughlin, et al. 2008 Tissue Specific Actions of the Ept1, Ept2, Ept6 and Ept9 genetic determinants of responsiveness to estrogens in the female rat Endocrinology 149 8 3850 3859 18420736 10.1210/en.2008-0173 1:CAS:528:DC%2BD1cXptlamsbw%3D
22. JL Masferrer KM Leahy AT Koki, et al. 2000 Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 5 1306 1311 10728691 1:CAS:528:DC%2BD3cXhvFWrt74%3D
23. AM Fulton P Gimotty E Alonsozana, et al. 2000 Elevated prostaglandin E2 (PGE2) levels in human breast cancer are associated with poor long-term survival Proc Am Assn Cancer Res 41 3660A
24. A Ristimaki A Sivula J Lundin, et al. 2002 Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 3 632 635 11830510 1:CAS:528:DC%2BD38Xht1KrtLg%3D
25. Norman A, Litwack G (1997) Hormones, 2nd edn. Academic Press, San Diego
26. TJ Spady KL Pennington RD McComb, et al. 1999 Estrogen-induced pituitary tumor development in the ACI rat not inhibited by dietary energy restriction Mol Carcinog 26 4 239 253 10569801 10.1002/(SICI)1098-2744(199912)26:4<239::AID- MC3>3.0.CO;2-H 1:CAS:528:DyaK1MXnvF2mtLg%3D
27. S Ravoori MV Vadhanam S Sahoo, et al. 2007 Mammary tumor induction in ACI rats exposed to low levels of 17beta-estradiol Int J Oncol 31 1 113 120 17549411 1:CAS:528:DC%2BD2sXot1Kqu7c%3D
28. SA Li SJ Weroha O Tawfik, et al. 2002 Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation J Endocrinol 175 2 297 305 12429028 10.1677/joe.0.1750297 1:CAS:528:DC%2BD38XptlaktLc%3D (Pubitemid 35422606)
29. TE Yankeelov LM DeBusk DD Billheimer, et al. 2006 Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T J Magn Reson Imaging 24 5 1140 1147 17024660 10.1002/jmri.20729 (Pubitemid 44658253)
30. DJ Rowland JR Garbow R Laforest, et al. 2005 Registration of [18F]FDG microPET and small-animal MRI Nucl Med Biol 32 6 567 572 16026703 10.1016/j.nucmedbio.2005.05.002 1:CAS:528:DC%2BD2MXmsVWns74%3D (Pubitemid 40981812)
31. K Turetschek A Preda E Floyd, et al. 2003 MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model Eur J Nucl Med Mol Imaging 30 3 448 455 12722742 1:CAS:528:DC%2BD3sXitFGmtbY%3D
32. P Marzola S Ramponi E Nicolato, et al. 2005 Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents Invest Radiol 40 7 421 429 15973133 10.1097/01.rli.0000167124.89782.db 1:CAS:528:DC%2BD2MXlsVertb0%3D (Pubitemid 40863785)
33. BK Dunn DL Wickerham LG Ford 2005 Prevention of hormone-related cancers: breast cancer J Clin Oncol 23 2 357 367 15637398 10.1200/JCO.2005.08.028 (Pubitemid 46209965)
34. E Banks V Beral D Bull, et al. 2003 Breast cancer and hormone-replacement therapy in the million women study Lancet 362 419 427 10.1016/S0140-6736(03) 14096-2 (Pubitemid 36999699)
35. DJ Slamon GM Clark SG Wong, et al. 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 4785 177 182 3798106 10.1126/science.3798106 1:CAS:528:DyaL2sXhtVSht7s%3D
36. RE Harris J Beebe-Donk GA Alshafie 2006 Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors BMC Cancer 6 27 16445867 10.1186/1471-2407-6-27 (Pubitemid 43264309)